SAN FRANCISCO — A handful of years later, transcatheter aortic valve replacement (TAVR) still compared well against surgery in the PARTNER 3 and Evolut Low Risk trials.
PARTNER 3 a… Read More
SenesTech (NASDAQ: SNES), the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, presented virtually in a webcast presentation… Read More
Physicians have higher suicide rates than the general population, with surgeons as one of the top groups at risk of taking their lives in the medical field. The Guardian takes a deep dive in… Read More
SAN FRANCISCO — Two mainstream devices for percutaneous left atrial appendage (LAA) closure continued to lead to similar clinical outcomes in the SWISS-APERO trial.
Among patients… Read More
[Research Report] The transdermal drug delivery system market is expected to grow from US$ 37,230.28 million in 2022 to US$ 51,949.74 million by 2030; it is anticipated to record a CAGR… Read More